These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 15088342

  • 1. [Intratympanic gentamicin in Menière's disease].
    Huang W, Xu H, Gao B.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [Abstract] [Full Text] [Related]

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

  • 5. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE, Kamerer DB.
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [Abstract] [Full Text] [Related]

  • 6. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N, Boleas MS, Martin E.
    Audiol Neurootol; 2005 Jan; 10(2):69-78. PubMed ID: 15650298
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 8. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
    Wang XY.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun 20; 30(12):942-944. PubMed ID: 29771059
    [Abstract] [Full Text] [Related]

  • 9. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH.
    Acta Otolaryngol; 2009 Dec 20; 129(12):1420-4. PubMed ID: 19922092
    [Abstract] [Full Text] [Related]

  • 10. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G, Chung DW, van der Hoeven R, Verweij S, Becker M.
    Int J Clin Pharm; 2016 Aug 20; 38(4):780-3. PubMed ID: 27073077
    [Abstract] [Full Text] [Related]

  • 11. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W, Szyfter W, Lączkowska-Przybylska J, Szyfter-Harris J.
    Otolaryngol Pol; 2012 Aug 20; 66(1):20-6. PubMed ID: 22381010
    [Abstract] [Full Text] [Related]

  • 12. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M, Marsan J, Schramm D, Robichaud J.
    J Otolaryngol; 1997 Dec 20; 26(6):361-4. PubMed ID: 9438932
    [Abstract] [Full Text] [Related]

  • 13. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr 20; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 14. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K, Krzeska-Malinowska I, Kowalska M, Bartoszewicz R, Niemczyk K.
    Otolaryngol Pol; 2005 Apr 20; 59(3):409-13. PubMed ID: 16117399
    [Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr 20; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 16. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
    Gabra N, Saliba I.
    Otolaryngol Head Neck Surg; 2013 Apr 20; 148(4):642-7. PubMed ID: 23314159
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic gentamicin in Ménière's disease: results of therapy.
    Murofushi T, Halmagyi GM, Yavor RA.
    Am J Otol; 1997 Jan 20; 18(1):52-7. PubMed ID: 8989952
    [Abstract] [Full Text] [Related]

  • 18. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A, Aloisi A, De Benedittis G, Scaringi A.
    Ann N Y Acad Sci; 1999 Nov 28; 884():410-24. PubMed ID: 10842610
    [Abstract] [Full Text] [Related]

  • 19. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep 28; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 20. Intratympanic gentamicin treatment after endolymphatic sac surgery.
    Gouveris H, Lange G, Mann WJ.
    Acta Otolaryngol; 2005 Nov 28; 125(11):1180-3. PubMed ID: 16353396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.